Clinical Trial Update: Expanded Access to Bimatoprost (Durysta)

View source ↗

Summary

Expanded access to the Durysta bimatoprost implant for open-angle glaucoma is updated, noting that the program is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• DURYSTA (BIMATOPROST)

Snippet

Sponsor: AbbVie | Conditions: Open-angle Glaucoma | Status: NO_LONGER_AVAILABLE